Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.

CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis. Abstract Text:

    nikolaos bonarosNikolaos Bonaros,bernd mayerBernd Mayer,thomas schachnerThomas Schachner, laufer Laufer,alfred kocherAlfred Kocher,nikolaos bonarosNikolaos Bonaros,bernd mayerBernd Mayer,thomas schachnerThomas Schachner,günther lauferGünther Laufer,alfred kocherAlfred Kocher,nikolaos bonarosNikolaos Bonaros,bernd mayerBernd Mayer,thomas schachnerThomas Schachner,günther lauferGünther Laufer,alfred kocherAlfred Kocher,

    OBJECTIVE: The goal of this meta-analysis was to investigate the impact of cytomegalovirus hyperimmune globulin (CMVIG) on cytomegalovirus (CMV) infection, CMV disease, and mid-term survival in solid organ transplant recipients. METHODS: Medline, EMBASE, and the Cochrane databases were searched since their inceptions until 2006. Inclusion criteria comprised: prospective randomized trials, in solid organ transplantation which received CMV prophylaxis including CMVIG on one of the treatment arms. Random effects models were used to calculate pooled risk ratios (RR) and meta-regression was employed to explain study heterogeneity. Stratified analyses were conducted and Funnel plot was used to assess publication bias. RESULTS: Literature searches identified 11 randomized trials (698 patients; median follow-up: 12 months, range: 3-22 months) including six randomized trials (302 patients) after kidney transplantation. The analysis demonstrated a beneficial effect of the prophylactic use of CMVIG on total survival [RR (95% confidence interval; CI): 0.67 (0.47-0.95)] and prevention of CMV-associated death [RR (95% CI): 0.45 (0.24-0.84)] in solid organ transplant recipients but not kidney transplant recipients [RR (95% CI): 0.35 (0.12-1.04)]. CMV disease was significantly reduced in all recipients receiving prophylactic CMVIG [RR (95% CI): 0.697 (0.57-0.85)]. CMVIG had no impact on CMV-infections and clinically relevant rejections. CONCLUSIONS: Prophylactic administration of CMVIG after solid organ transplantation is associated with improved total survival, reduced CMV disease, and CMV-associated deaths.

    CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis. Publishing Authors By Initials

    n bonarosN Bonaros,b mayerB Mayer,t schachnerT Schachner,g lauferG Laufer,a kocherA Kocher,n bonarosN Bonaros,b mayerB Mayer,t schachnerT Schachner,g lauferG Laufer,a kocherA Kocher,n bonarosN Bonaros,b mayerB Mayer,t schachnerT Schachner,g lauferG Laufer,a kocherA Kocher,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Clinical transplantation

    VOLUME: 22

    Page Numbers: 89-97

    Journal Abbreviation:

    ISSN: 1399-0012

    DAY: 25

    MONTH: 01

    YEAR: 2008

    CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8710240

    CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis.

    AFFILIATION: Department of Cardiac Surgery, Innsbruck, Medical University, Innsbruck, Austria. nikolaos.bonaros@i-med.ac.at

    Country: Denmark

    Denmark Research PublicationDenmark Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Clin Transplant

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    CMV-hyperimmune globulin for preventing cytomegalovirus infection and disease in solid organ transplant recipients: a meta-analysis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News